NEW YORK, July 21 (GenomeWeb News) - The Broad Institute will use Affymetrix's genotyping arrays to conduct whole-genome association studies looking into the genetic causes of cancer, cardiovascular, metabolic, and neuropsychiatric diseases, the company said today.
Institute researchers and their collaborators in academia and industry plan to use Affy's GeneChip Mapping 500K arrays to analyze 12,000 human DNA samples, generating more than 6 billion genotypes. They also plan to develop new laboratory and analysis methods for the arrays, which they will use under an early access program.
Affymetrix said it expects to launch the 500K arrays commercially later this year.